Skip to main content
Premium Trial:

Request an Annual Quote

Diagnostic Hybrids Awarded US Patent

Premium
Diagnostic Hybrids has been awarded US Patent 7,341,829, “In situ growth, freezing and testing of cultured cells.”
 
The inventors listed on the patent are David Scholl, Francesco Ambesi-Impiombato, James Brown, Leonard Kohn, and Joseph Jollick, Jr.
 
According to its abstract, the patent provides methods for the in situ growth, freezing, and testing of cultured cells. Specifically, the patent describes methods for the long-term preservation of cells in ready-to-use formats for testing. The patent also provides rapid and easy-to-use methods to diagnose viral and other infections. In addition, the patent discusses easy-to-use methods to grow and store cells in situ for testing methods.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.